InMed Pharmaceuticals Inc. (INM) Stock Analysis
DELISTED
What happened to InMed Pharmaceuticals Inc. (INM) stock?
InMed Pharmaceuticals Inc. (INM) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 14.58 means the share price is 14.58 times one year of earnings per share. Market cap $8.55M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
InMed Pharmaceuticals Inc. (INM). InMed Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on researching and developing cannabinoid-based therapies for various diseases, including epidermolysis bullosa, glaucoma, and pain.
Last analyzed: Jun 15, 2026InMed Pharmaceuticals Inc. (INM) Healthcare & Pipeline Overview
More about this archive record
Can I still buy INM shares?
No. INM stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for INM elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before INM stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to InMed Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.